| Variation | | Type (Consequence) | Condition | Classification, Review status |
|---|
| | CTNNB1, LOC126806658 (D32Y +1 more) | Single nucleotide variant (missense variant) | Gastric adenocarcinoma +10 more | GPathogenic/Likely pathogenic; other |
| | CTNNB1, LOC126806658 (S33C +1 more) | Single nucleotide variant (missense variant) | Malignant melanoma of skin +13 more | GLikely pathogenic; other |
| | LOC126806658, CTNNB1 (S33F +1 more) | Single nucleotide variant (missense variant) | Carcinoma of esophagus +13 more | GPathogenic/Likely pathogenic; other |
| | CTNNB1, LOC126806658 (G34E +1 more) | Single nucleotide variant (missense variant) | Malignant neoplasm of body of uterus +9 more | GPathogenic/Likely pathogenic; other |
| | CTNNB1, LOC126806658 (T41A +1 more) | Single nucleotide variant (missense variant) | Desmoid tumor | |
| | LOC126806658, CTNNB1 (S45F +1 more) | Single nucleotide variant (missense variant) | Adrenal cortex carcinoma +11 more | GPathogenic/Likely pathogenic; other |
| | | Single nucleotide variant (missense variant) | Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes | |
| | | Single nucleotide variant (missense variant) | Hepatocellular carcinoma | |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome | |
Click to view in NCBI Gene